Cellugen Biotech Private Limited, a under cirp private limited company, was established on 18 August 2008 in New Delhi, Delhi, India. Engaging in pharmaceutical retailers & distributors within the professional, scientific and technical sector, it holds CIN: U85110DL2008PTC182124. Registered under ROC Roc Delhi. it is unlisted. It has an authorized capital of ₹1.00 Cr and a paid-up capital of ₹1.00 Cr.
Formerly known as Unistem Biosciences Private Limited, Beike Biotech India Private Limited. It upholds a compliant status. Its leadership includes Lalit Jaiswal (Director), Kangan Jaiswal (Director). Past directors included Kanishk Jaiswal, Umesh Arunbhai Yagnik, Kangan Jaiswal. It holds ₹5.67 Cr open charges and no settled loans. Its latest AGM occurred on 19 September 2019, with the balance sheet filed on 31 March 2019. It is based at Innov8 Coworking, Salcon Rasvilas, Lgf, Next To Select City Walk, Saket District Centre, Saket District, Sector 6, Pushp Vihar, New Delhi- 110017., New Delhi, Delhi, 110017.
U85110DL2008PTC182124
182124
18 August 2008
₹1.00 Cr
₹1.00 Cr
Roc Delhi
Unlisted
Under Cirp
Explore comprehensive insights into Cellugen Biotech Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Lalit Jaiswal | Director | 18 Aug 2008 | Current |
| Kangan Jaiswal | Director | 25 Mar 2016 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 07 Apr 2022 | Past |
| Pramod Abcsdd | Director | 05 Jan 2022 | Past |
| Pramod Abcsdd | Additional Director | 30 Sep 2016 | Past |
| Pramod Abcsdd | Director | 07 Apr 2022 | Past |
| Pramod Abcsdd | Director | 02 Apr 2019 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Cellugen Biotech Private Limited, for the financial year ended 2019, experienced modest growth in revenue, with a 3.56% increase. The company also saw a slight decrease in profitability, with a 4.34% decrease in profit. The company's net worth moved up by a moderate rise of 1.26%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2019, Cellugen Biotech had a promoter holding of 83.00% and a public holding of 17.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹56,652,941.00
₹0
| Date | Lender | Amount | Status |
|---|---|---|---|
| 27 Oct 2020 | Others | ₹6.65 M | Open |
| 25 Oct 2018 | Others | ₹5.00 Cr | Open |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Cellugen Biotech, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Cellugen Biotech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Cellugen Biotech's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
A charge with Others amounted to Rs. 0.67 Cr with Charge ID 100384919 was registered on 27 Oct 2020. was recorded as a recent event.
Progress on Cellugen Biotech Private Limited last Annual general meeting of members was held on 19 Sep 2019 as per latest MCA records. was documented.
The activity Cellugen Biotech Private Limited has filed its annual Financial statements for the year ended 31 Mar 2019 with Roc Delhi. was completed.
A charge with Others amounted to Rs. 5.00 Cr with Charge ID 100213634 was registered on 25 Oct 2018. was recorded as a recent event.
Kangan Jaiswal was appointed as a Director was appointed as a Director on 25 Mar 2016 & has been associated with this company since 9 years 8 months . was recorded as a recent event.
The activity Lalit Jaiswal was appointed as a Director was appointed as a Director on 18 Aug 2008 & has been associated with this company since 17 years 3 months . was completed.
The CIN of Cellugen Biotech Private Limited is U85110DL2008PTC182124.
Cellugen Biotech Private Limited is headquartered at Innov8 Coworking, Salcon Rasvilas, Lgf, Next To Select City Walk, Saket District Centre, Saket District, Sector 6, Pushp Vihar, New Delhi- 110017., New Delhi, Delhi, 110017.
Cellugen Biotech Private Limited was incorporated on 18 August 2008.
The current directors of Cellugen Biotech Private Limited are
The primary industry of Cellugen Biotech Private Limited is Professional, Scientific And Technical.
Cellugen Biotech Private Limited is unlisted.
The authorized capital of Cellugen Biotech Private Limited is ₹1.00 Cr, and the paid-up capital is ₹1.00 Cr.
The compliance status of Cellugen Biotech Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX